Brief: Humanigen Announces Peer-Reviewed Publication Demonstrating The Potential Clinical, Economic Benefits Of Lenzilumab From The Perspective Of The NHS
19/04/2022 11:32
April 19 (Reuters) - Humanigen Inc HGEN.O :
* HUMANIGEN ANNOUNCES PEER-REVIEWED PUBLICATION
DEMONSTRATING THE
POTENTIAL CLINICAL AND ECONOMIC BENEFITS OF LENZILUMAB FROM THE
PERSPECTIVE OF THE NHS
Source text for Eikon: ID:nBw9SYQQja
Further company coverage: HGEN.O
Recent news on Humanigen
See all newsPress Digest: Wall Street Journal - Jan 5
Covid: 19 treatment developer Humanigen files for Chapter 11 bankruptcy
Brief: Humanigen Files For Voluntary Chapter 11 Bankruptcy - Court Filing
Brief: Covid-19 Treatment Developer Humanigen Files For Bankruptcy - WSJ
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners